Form D · Biotechnology
Oncternal Therapeutics, Inc.
San Diego, CA · CIK 0001600987
Offering snapshot reported Nov 21, 2018 · SEC filing
- Reported sold
- $17M Offering amount: $24M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 7, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 21, 2018 | Initial | $17,000,000 | No comparison | 1 | SEC filing |
| Sep 27, 2017 | Initial | $6,850,397 | No comparison | 121 | SEC filing |
| Mar 23, 2017 | Amendment | $17,874,045 | $6,592,311vs Dec 9, 2016 | 111 | SEC filing |
| Dec 9, 2016 | Amendment | $11,281,734 | $8,131,739vs Aug 7, 2015 | 95 | SEC filing |
| Oct 20, 2016 | Amendment | $6,083,738 | $2,933,743vs Aug 7, 2015 | 72 | SEC filing |
| Jul 8, 2016 | Initial | $150,000 | No comparison | 3 | SEC filing |
| Jun 8, 2016 | Initial | $13,135,714 | No comparison | 26 | SEC filing |
| Mar 10, 2016 | Amendment | $3,709,993 | $559,998vs Aug 7, 2015 | 39 | SEC filing |
| Aug 7, 2015 | Initial | $3,149,995 | No comparison | 30 | SEC filing |
| Mar 5, 2014 | Initial | $3,090,000 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-326302
Source: Form D, filed Nov 21, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James B. Breitmeyer, M.D., Ph.D. | Director, Executive |
| Cooper Collins | Director |
| James Freddo | Executive |
| Cam Gallagher | Director |
| Cam L. Garner | Director |
| Scott L. Glenn | Director |
| David F. Hale | Director |
| David Johnson | Director |
| Brian Lannutti | Executive |
| William R. La Rue | Director |
| Karen Lundgren | Executive |
| Dana Mc Gowan | Executive |
| Langdon Miller | Executive |
| Lauren G. Otsuki | Executive |
| Charles Theuer, M.D. | Director |
| Richard Vincent | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3525 Del Mar Heights Rd., #821
San Diego, CA, 92130
San Diego, CA, 92130